cGMP (cyclic guanosine 3', 5'-monophosphate), a second messenger, is produced due to the catalyzation on the guanosine triphosphate (GTP) by guanylate cyclase (GC). cGMP has three main targets: cGMP-dependent protein kinase or protein kinase G (PKG), cGMP-regulated phosphodiesterase (PDE), and cyclic nucleotide cationic gated channelcyclic guanosine-gated ion channel (CNG). PKG, a universal eukaryotic Ser/Thr kinase, is the most important downstream target of cGMP.
In the cGMP-PKG signaling pathway, PKG is activated by the second messenger cGMP and then transmits extracellular signals into the cell.
cGMP-PKG signaling pathway mediates many processes such as the regulation of relaxation and contraction of vascular smooth muscle cells, anti - cardiac hypertrophy, anti-atherosclerosis, and anti-vascular injury/restenosis.
Nitric oxide (NO) stimulates soluble guanylate cyclase (sGC) to catalyze the intracellular synthesis of cGMP. cGMP activates PKG. Active PKG phosphorylates PLB (phospholamban) on the sarcoplasmic reticulum (SR). Phosphorylated PLB dissociates from Ca2+-ATPase (SERCA-2a) and restores Ca2+-ATPase activity. Activated Ca2+-ATPase transfers Ca2+ from cytoplasm to the sarcoplasmic reticulum, making intracellular Ca2+ level decline. And PKG (PKG-β) catalyzes the phosphorylation of IRAG (IP3 receptor-associated PKG-I substrate), inhibiting the release of Ca2+ mediated by IP3R. These two processes cause Ca2+ to accumulate in the sarcoplasmic reticulum. And then, the accumulated Ca2+ is released into the lower region of the cytoplasmic membrane, triggering spontaneous outward current and activating BK channels. The final result is to realize cardiomyocytes' relaxation.
Or the activation of particulate guanylate cyclase (PGC) by ANP (atrial natriuretic peptide) facilitates the production of cGMP. PKG is subsequently activated by increased cGMP, which phosphorylates protein substrates, causing cellular effects, such as decreased intracellular Ca2+ concentrations in smooth muscle and platelets.
|ADCY1||ADCY1 Antibody||ADCY1 Protein||ADCY1 cDNA||ADCY1 ELISA Kit|
|ADCY2||ADCY2 Antibody||ADCY2 Protein||ADCY2 cDNA||ADCY2 ELISA Kit|
|ADCY3||ADCY3 Antibody||ADCY3 Protein||ADCY3 cDNA||ADCY3 ELISA Kit|
|ADCY4||ADCY4 Antibody||ADCY4 Protein||ADCY4 cDNA||ADCY4 ELISA Kit|
|ADCY5||ADCY5 Antibody||ADCY5 Protein||ADCY5 cDNA||ADCY5 ELISA Kit|
|ADCY6||ADCY6 Antibody||ADCY6 Protein||ADCY6 cDNA||ADCY6 ELISA Kit|
|ADCY7||ADCY7 Antibody||ADCY7 Protein||ADCY7 cDNA||ADCY7 ELISA Kit|
|ADCY8||ADCY8 Antibody||ADCY8 Protein||ADCY8 cDNA||ADCY8 ELISA Kit|
|ADCY9||ADCY9 Antibody||ADCY9 Protein||ADCY9 cDNA||ADCY9 ELISA Kit|
|ADORA1||ADORA1 Antibody||ADORA1 Protein||ADORA1 cDNA||ADORA1 ELISA Kit|
|ADORA3||ADORA3 Antibody||ADORA3 Protein||ADORA3 cDNA||ADORA3 ELISA Kit|
|ADRA1A||ADRA1A Antibody||ADRA1A Protein||ADRA1A cDNA||ADRA1A ELISA Kit|
|ADRA1B||ADRA1B Antibody||ADRA1B Protein||ADRA1B cDNA||ADRA1B ELISA Kit|
|ADRA1D||ADRA1D Antibody||ADRA1D Protein||ADRA1D cDNA||ADRA1D ELISA Kit|
|ADRA2A||ADRA2A Antibody||ADRA2A Protein||ADRA2A cDNA||ADRA2A ELISA Kit|
|ADRA2B||ADRA2B Antibody||ADRA2B Protein||ADRA2B cDNA||ADRA2B ELISA Kit|
|ADRA2C||ADRA2C Antibody||ADRA2C Protein||ADRA2C cDNA||ADRA2C ELISA Kit|
|ADRB1||ADRB1 Antibody||ADRB1 Protein||ADRB1 cDNA||ADRB1 ELISA Kit|
|ADRB2||ADRB2 Antibody||ADRB2 Protein||ADRB2 cDNA||ADRB2 ELISA Kit|
|ADRB3||ADRB3 Antibody||ADRB3 Protein||ADRB3 cDNA||ADRB3 ELISA Kit|